Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avatrombopag for Persistent Chemotherapy-Induced Thrombocytopenia in Gastrointestinal Malignancies
NCT05772546Phase 2Completed
- Start
- Nov 2023
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of avatrombopag in chemotherapy-induced thrombocytopenia (CIT). Started Nov 2023; status: completed.
02
Drugs
avatrombopag
03
Conditions
chemotherapy-induced thrombocytopenia (CIT)
Beyond the preview
Go deeper on NCT05772546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05772546.